Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.
Saved in:
| Title: | Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. |
|---|---|
| Authors: | Vu, Tuan1 (AUTHOR) tvu6@usf.edu, Meisel, Andreas2 (AUTHOR), Mantegazza, Renato3 (AUTHOR), Annane, Djillali4 (AUTHOR), Katsuno, Masahisa5 (AUTHOR), Aguzzi, Rasha6 (AUTHOR), Enayetallah, Ahmed6 (AUTHOR), Beasley, Kathleen N.6 (AUTHOR), Rampal, Nishi6 (AUTHOR), Howard Jr., James F.7 (AUTHOR) |
| Source: | Neurology & Therapy. Oct2023, Vol. 12 Issue 5, p1435-1438. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
